Foundry Partners LLC Buys 67,157 Shares of Select Medical Holdings Co. (NYSE:SEM)

Foundry Partners LLC increased its holdings in shares of Select Medical Holdings Co. (NYSE:SEMFree Report) by 31.8% in the third quarter, according to its most recent filing with the SEC. The fund owned 278,433 shares of the health services provider’s stock after acquiring an additional 67,157 shares during the period. Foundry Partners LLC owned about 0.22% of Select Medical worth $7,036,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Public Employees Retirement System of Ohio lifted its holdings in shares of Select Medical by 6.8% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 7,386 shares of the health services provider’s stock worth $163,000 after buying an additional 473 shares during the period. Ameritas Investment Partners Inc. lifted its holdings in shares of Select Medical by 6.0% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 8,588 shares of the health services provider’s stock worth $274,000 after buying an additional 486 shares during the period. Great West Life Assurance Co. Can lifted its holdings in shares of Select Medical by 0.7% in the 1st quarter. Great West Life Assurance Co. Can now owns 93,400 shares of the health services provider’s stock worth $2,297,000 after buying an additional 604 shares during the period. LPL Financial LLC lifted its holdings in shares of Select Medical by 4.4% in the 4th quarter. LPL Financial LLC now owns 16,978 shares of the health services provider’s stock worth $422,000 after buying an additional 714 shares during the period. Finally, Yousif Capital Management LLC lifted its holdings in shares of Select Medical by 0.9% in the 1st quarter. Yousif Capital Management LLC now owns 96,181 shares of the health services provider’s stock worth $2,307,000 after buying an additional 813 shares during the period. 76.95% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Select Medical news, Chairman Robert A. Ortenzio sold 50,000 shares of the stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $26.00, for a total transaction of $1,300,000.00. Following the transaction, the chairman now owns 6,789,668 shares in the company, valued at $176,531,368. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Chairman Robert A. Ortenzio sold 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $26.00, for a total value of $1,300,000.00. Following the transaction, the chairman now owns 6,789,668 shares in the company, valued at $176,531,368. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Chairman Robert A. Ortenzio sold 100,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 14th. The shares were sold at an average price of $25.00, for a total value of $2,500,000.00. Following the completion of the transaction, the chairman now owns 6,939,668 shares in the company, valued at approximately $173,491,700. The disclosure for this sale can be found here. Insiders have sold a total of 250,000 shares of company stock valued at $6,463,000 over the last ninety days. Company insiders own 19.14% of the company’s stock.

Analyst Upgrades and Downgrades

SEM has been the subject of a number of analyst reports. Benchmark restated a “buy” rating and set a $39.00 price objective on shares of Select Medical in a research note on Wednesday, November 8th. TheStreet lowered Select Medical from a “b-” rating to a “c+” rating in a research report on Friday, November 3rd. Finally, UBS Group began coverage on Select Medical in a research report on Thursday, November 30th. They set a “neutral” rating and a $26.00 target price on the stock. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $34.40.

Get Our Latest Stock Analysis on SEM

Select Medical Stock Performance

Shares of SEM stock traded up $0.12 during mid-day trading on Monday, reaching $26.52. The stock had a trading volume of 30,474 shares, compared to its average volume of 620,050. The business’s fifty day moving average is $25.24 and its 200-day moving average is $25.54. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 2.43. The firm has a market cap of $3.40 billion, a price-to-earnings ratio of 14.92, a PEG ratio of 0.53 and a beta of 1.35. Select Medical Holdings Co. has a 1-year low of $21.28 and a 1-year high of $33.51.

Select Medical Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: The Critical Illness Recovery Hospital, The Rehabilitation Hospital, The Outpatient Rehabilitation, and The Concentra.

Featured Articles

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.